Skip to main content

1 Result(s)

within Xue-feng Kan Remove this filter

and

  1. No Access

    Article

    Transarterial Chemoembolization Combined with Apatinib for Treatment of Advanced Hepatocellular Carcinoma: Analysis of Survival and Prognostic Factors

    Apatinib is a novel inhibitor of vascular endothelial growth factor receptor-2. The goal of this study was to evaluate overall survival (OS) after a combination of transarterial chemoembolization (TACE) and ap...

    Zi-yi Liu, Xue-feng Kan, Li-jie Zhang, Joyman Makamure, Qing Li… in Current Medical Science (2022)